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New therapeutic targets are needed that circumvent inherent therapeutic resistance of 22 glioblastoma multiforme (GBM). Here we report such a candidate target in the uncharacterized 23 adaptor protein hMOB3, which we show is upregulated in GBM. In a search for its biochemical 24 function, we found that hMOB3 specifically interacts with MST1 kinase in response to apoptotic 25 stimuli and cell-cell contact. Moreover, hMOB3 negatively regulated apoptotic signaling by 
Results
110
hMOB3 is overexpressed in human GBM
111
In a previous study, we performed a microarray analysis of 30 human gliomas (41). Interestingly,
112
the mRNA levels of uncharacterized hMOB3 family members were found to be deregulated in
113
GBM. Of these, hMOB3A and hMOB3C expression were elevated while hMOB3B was 
120
Using this novel antibody, we determined the total hMOB3 protein levels in human GBM To explore the potential prognostic value of hMOB3, we compared clinical outcome and 128 hMOB3 gene expression using the Rembrandt database (43). In agreement with our finding of 129 upregulation of hMOB3A and hMOB3C (Supplemental Figure 1A) , we did not identify any 130 sample with hMOB3A and hMOB3C downregulation in human GBM in Rembrandt dataset
131
(data not shown). Because of limited GBM sample numbers, we extended our analysis from
132
"GBM" to "all glioma". In this dataset, we found a statistically significant correlation between 133 poor survival and high mRNA expression of hMOB3A and hMOB3C ( Figure 1D alterations in the hMOB3B genomic locus. We further generated Kaplan-Meier curves for 142 differential hMOB3B gene expression from the same dataset ( Figure 1E (ii)). Since records for 143 normal human brain control tissue were not available, we followed the common strategy to 144 define the top 25% of the samples with highest expression as "Up" and the 25% with lowest 145 hMOB3B expression as "Down". Based on these criteria, 50% survival of patients with low 146 hMOB3B levels was reduced by 40% compared to patients with high hMOB3B levels (10 versus 147 16.6 months). These findings indicate that downregulation of hMOB3B predicts poor survival,
148
fully consistent with the results from the Rembrandt dataset. To investigate the discrepancy between upregulated total hMOB3 protein levels in human GBM 150 and its variable prognostic values from the Rembrand and TCGA mRNA datasets, we studied the 151 interplay within hMOB3 members by single knockdown of the most variable member, hMOB3B.
152
Interestingly, upregulation of total hMOB3 protein in U373MG cells by specific knockdown of 153 hMOB3B pointed towards compensatory mechanisms of hMOB3A/C and hMOB3B
154
(Supplemental Figure 1D) . Therefore, it appears that depletion of hMOB3B results in the 155 upregulation of hMOB3A/C protein, which indicates that low levels of hMOB3B in GBM might 156 result in high hMOB3A/C levels. This could potentially explain the observed association 157 between poor survival and low hMOB3B expression ( Figure 1D ).
158
Collectively, our analysis indicates that total hMOB3 is up-regulated at the protein level in GBM 159 and that expression of hMOB3A/B/C is associated with clinical outcomes. Based on these 160 findings it is tempting to speculate that total hMOB3 protein has proto-oncogenic properties. Figure 2D ).
191
To gain insight into the domains of MST1 responsible for binding to hMOB3, we generated a 192 series of MST1 truncation mutants illustrated in Figure 3A . We tested the interaction between 193 these mutants and wild-type hMOB3A by co-immunoprecipitation and found that the minimal Next, we asked whether the kinase activity of MST1 is required for its interaction with hMOB3. .
203
As illustrated in Figure 3A 
209
We also observed the binding of MST1T 183 E and hMOB3 at 50% cell density (Supplemental 210 Figure 2F ), further indicating that phosphorylation of threonine 183 is critical for the interaction. 
decrease in total levels of cleaved MST1, nuclear cleaved MST1 was also significantly reduced 238 in hMOB3-overexpressing U373MG cells ( Figure 4C ). Histone H2B has been reported to be a 239 key substrate mediating apoptotic MST1 signaling (24). We further analyzed H2B Ser 14 240 phosphorylation in response to etoposide and found a decrease in Ser 14 phosphorylation in 241 hMOB3B-overexpressing U373MG cells ( Figure 4D ).
242
To further test our conclusions on the effect of endogenous hMOB3 on MST1 cleavage and 243 apoptosis, and given the functional redundancy of hMOB3A/B/C ( Figure 4A-B) , we generated a Figure 4F and Figure 4H ). Collectively, these data further support the notion that 257 hMOB3 negatively regulates apoptotic cleavage of MST1 in GBM cells.
258
To examine whether there is any correlation between hMOB3 protein levels and the apoptotic Figure 5A) . Surprisingly, we found that these two residues, (41, 42). In the present study, we have discovered that the previously uncharacterized adaptor 319 protein hMOB3A/B/C is deregulated in GBM (Figure 1 ). Of note, we found that hMOB3A and 320 hMOB3C were increased at the mRNA level (Supplemental figure 1A) . Consistent with our 321 findings, data obtained from the Rembrandt database also showed upregulation of hMOB3A and 322 hMOB3C in human GBM samples ( Figure 1D) ; conversely, hMOB3B appears to be CAN-13-3430 and TCGA datasets. Importantly, we found that total hMOB3 protein levels were prominently 327 upregulated in human GBM samples ( Figure 1A, 1B and 1C proto-oncogenic function of hMOB3. In an attempt to reconcile the converse de-regulation of the 331 respective hMOB3 isoforms in GBM, we found that knockdown of hMOB3B resulted in an 332 upregulation of total hMOB3 protein levels (Supplemental Figure 1D) . This suggests that, in 333 response to inactivation of hMOB3B, compensatory upregulation of hMOB3A and C might 334 provide GBM cells with increased oncogenic potential. However, the basis of the compensation 335 mechanisms is currently unknown and requires further analysis.
336
While the role of hMOB1 protein has already been studied in tissue cultured cells and recently 337 confirmed in a knock-out mouse model (36, 38, 39), the function of hMOB3 protein remained 338 unknown. In a previous study we found that hMOB3 does not interact with NDR or LATS (34), 339 but did not address MST1 as a potential interaction partner. As hMOB1 interacts with hMOB1,
340
we asked whether hMOB3 might do so as well. Indeed, we observed that all three hMOB3 341 isoforms directly interact with mammalian Hippo, MST1 (Figure 2) . Importantly, the 342 hMOB3/MST1 interaction is induced by apoptosis and high cell density. Moreover, MST1 343 kinase activity is required for the interaction ( Figure 3B, 3D and 3E ). MST1 kinase activity is 
MST1 is a well-characterized pro-apoptotic kinase that potentiates apoptosis by cross-talking curves for hMOB3 expression taken from the Rembrandt database. Cut-off is a twofold change.
521
P value is provided by the database using log-rank test. Curves represent all patients (blue), 
